Table 6:
Number of subjects with adverse events.
| Adverse events | 1 Hz | 5 Hz | 15 Hz |
|---|---|---|---|
| Fracture pelvis (withdrawn before randomization) | |||
| GI bleed secondary to NASIDS | 1 | ||
| Pneumonia | 1 | ||
| Skin discoloration | 1 | ||
| Kidney stone | 1 | ||
| Transient hand tingling and numbness | 1 | ||
| 5th metatarsal fracture | 1 | ||
| Joint pains | 1 | ||
| Back pain, leg tingling & numbness | 1 |